Bridgeway Capital Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,623
| Closed | -$38K | – | 1492 |
|
|
2022
Q3 | $38K | Sell |
5,623
-612
| -10% | -$4.14K | ﹤0.01% | 1364 |
|
|
2022
Q2 | $67K | Sell |
6,235
-1,500
| -19% | -$16.1K | ﹤0.01% | 1264 |
|
|
2022
Q1 | $173K | Hold |
7,735
| – | – | ﹤0.01% | 1193 |
|
|
2021
Q4 | $217K | Buy |
7,735
+5,450
| +239% | +$153K | ﹤0.01% | 1152 |
|
|
2021
Q3 | $149K | Sell |
2,285
-1,440
| -39% | -$93.9K | ﹤0.01% | 1229 |
|
|
2021
Q2 | $297K | Sell |
3,725
-545
| -13% | -$43.5K | 0.01% | 1210 |
|
|
2021
Q1 | $567K | Hold |
4,270
| – | – | 0.01% | 1058 |
|
|
2020
Q4 | $680K | Sell |
4,270
-125
| -3% | -$19.9K | 0.01% | 850 |
|
|
2020
Q3 | $462K | Hold |
4,395
| – | – | 0.01% | 919 |
|
|
2020
Q2 | $533K | Buy |
4,395
+1,997
| +83% | +$242K | 0.01% | 837 |
|
|
2020
Q1 | $188K | Sell |
2,398
-750
| -24% | -$58.8K | ﹤0.01% | 1075 |
|
|
2019
Q4 | $927K | Buy |
+3,148
| New | +$927K | 0.01% | 760 |
|